Knockdown of FGL1 could significantly increase the E-cadherin level of tumor cells and reduce the expression levels of vimentin and N-cadherin in tumor tissues, suggesting that FGL1 could promote the EMT process of gastric cancer (30). This evidence concerns the gene FGL1 and gastric cancer.